All Viruses articles – Page 7
-
NewsMost would recommend RSV immunizations for older and pregnant people
A US survey found an increase in awareness of immunizations that are available for RSV. The survey of 1,637 U.S. adults also found that about 6 in 10 respondents would recommend the vaccine or antibody injections to the groups recommended by the CDC, an increase from past years.
-
NewsLithium study yields insights in the fight against HIV
Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV. A new study found lithium can prevent infected cells from reactivating, and that it does so through an unexpected biological mechanism.
-
CareersThe National Collection of Pathogenic Viruses (NCPV): a critical resource for virology and public health
It’s now 25 years since the National Collection of Pathogenic Viruses (NCPV) was founded as a dedicated, secure, and relevant national virus repository for the UK. Jane Burton, Teresa Ramalho and Tilly Maybery explore how the collection has evolved - and is tackling future global health concerns.
-
NewsEngineered nanobodies improved respiratory defenses in preclinical study
Engineered nanobodies improved protection against multiple viruses by bolstering respiratory mucus. The bispecific design of the nanobodies works against viruses, like influenza, which can normally evade mucosal defenses.
-
NewsGlobal Virus Network warns of measles resurgence
The Global Virus Network (GVN) has expressed deep concern regarding the ongoing resurgence of measles in the United States and around the globe. Measles is one of the most contagious viral diseases known and can be lethal, particularly in unvaccinated children.
-
NewsHidden mpox exposure detected in healthy Nigerian adults, revealing under-recognized transmission
The mpox virus appears to be circulating silently in parts of Nigeria, in many cases without the symptoms typically associated with the disease, according to new research.
-
NewsHuman nasal passages defend against the common cold and help determine how sick we get
Researchers demonstrate how the cells in our noses work together to defend us from the common cold and suggest that our body’s defense to rhinovirus—not the virus itself—typically predicts whether or not we catch a cold, as well as how bad our symptoms will be.
-
NewsGolden Gate method enables rapid, fully-synthetic engineering of therapeutically relevant bacteriophages
Researchers have described the first fully synthetic bacteriophage engineering system for Pseudomonas aeruginosa. In this method, researchers engineer bacteriophages synthetically using sequence data rather than bacteriophage isolates.
-
NewsValneva provides update on Chikungunya vaccine IXCHIQ®
Valneva SE has announced that the company has decided to voluntarily withdraw the biologics license application (BLA) and Investigational New Drug (IND) application for its chikungunya vaccine, IXCHIQ® , in the United States, following suspension of the license by the FDA.
-
NewsShingles vaccine linked to slower biological aging in older adults
Shingles vaccination not only protects against the disease but may also contribute to slower biological aging in older adults, according to a new study.
-
News58% of patients affected by 2022 mpox outbreak report lasting physical symptoms
A cohort study found that more than half of those diagnosed with mpox during the 2022 outbreak still had lingering physical effects 11 to 18 months later.
-
NewsPregnant women hospitalized for COVID-19, and their newborns, have higher complication risk
When hospitalized for COVID-19, pregnant women — and their eventual newborn children — have a higher risk of complications. Research revealed that pregnant women were nearly 3.5 times more likely than non-pregnant women to require respiratory support when hospitalized for COVID-19.
-
NewsBat virome evolution reveals cross-species origins of porcine epidemic diarrhea virus and regional surveillance gaps
A study has unveiled the Indochina Peninsula’s bat virome diversity, offering key insights into the origins of porcine epidemic diarrhea virus (PEDV) and critical surveillance priorities.
-
NewsTB and HIV treatments are not enough for a full recovery
Existing treatments control TB and HIV, but the immune system does not revert to normal, helping explain why people living with HIV remain susceptible to infections and underscoring the need for immunotherapies.
-
NewsAboard the International Space Station, viruses and bacteria show atypical interplay
In a new study, terrestrial bacteria-infecting viruses were still able to infect their E. coli hosts in near-weightless “microgravity” conditions aboard the International Space Station, but the dynamics of virus-bacteria interactions differed from those observed on Earth.
-
NewsScientists observe infections by cancer-causing retroviruses in koalas as they occur
Scientists analysed the ongoing colonization by two retroviruses of the germline of koalas and resulting deaths from cancer in multi-generational pedigrees of over 100 koalas in US and European zoos. They calculated genetic risk scores (GRS) that can help guide koala breeding programs.
-
NewsWhen a virus releases the immune brake: New evidence on the onset of multiple sclerosis
A study investigating the links between Epstein-Barr virus and multiple sclerosis shows that EBV can interfere with the control of B cells. One viral protein mimics a crucial “approval” signal that B cells usually require from other immune cells. Self-reactive B cells can then survive even when they should be shut down.
-
NewsNew mechanism links Epstein-Barr virus to MS
Scientists investigating the links between the Epstein-Barr virus and multiple sclerosis show that when the immune system fights EBV, certain T cells – which normally attack the virus – can also react to a protein in the brain called Anoctamin-2 (ANO2), a phenomenon called molecular mimicry.
-
NewsGenetic risk factor and viral infection jointly contribute to MS
One of the leading triggers for multiple sclerosis (MS) is an infection with the Epstein-Barr virus. However, certain gene variants also play an important role. Researchers have shown that it is the molecular interaction between environmental and genetic risk factors that ultimately triggers the disease.
-
NewsNew hypothesis links HPV E6 and SARS‑CoV‑2 spike proteins to reduced p53 activity
Scientists have proposed a hypothesis suggesting that virally encoded proteins such as HPV-E6 or SARS-COV-2 Spike may cooperate in suppressing host defenses including tumor suppressor mechanisms involving p53.